Get startedLog in
    Picture of Calithera Biosciences logo

    CALA — Calithera Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Calithera Initiates Phase 1 Trial Of Cb-280 For Cystic Fibrosis

    Picture of Calithera Biosciences logoCalithera Biosciences
    13/07/2020 13:28
    July 13 (Reuters) - Calithera Biosciences Inc  CALA.O :
    * CALITHERA BIOSCIENCES INITIATES PHASE 1B TRIAL OF ARGINASE
INHIBITOR CB-280 FOR THE TREATMENT OF CYSTIC FIBROSIS

Source text for Eikon:  ID:nGNX9MMHqv 
Further company coverage:  CALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Calithera Biosciences

    See all news